Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02DPP
|
|||
| Former ID |
DIB004511
|
|||
| Drug Name |
MTHF
|
|||
| Synonyms |
N-[4-[2-Amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-ylmethylamino]benzoyl]-L-glutamic acid; 5-MTHF
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Phase 4 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Canonical SMILES |
C1C2CN(CN2C3=C(N1)NC(=NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00955955) Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive Disorder. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.